| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Metformin: an update.
|
Ann Intern Med
|
2002
|
5.62
|
|
2
|
Sleep duration among black and white Americans: results of the National Health Interview Survey.
|
J Natl Med Assoc
|
2008
|
3.82
|
|
3
|
Awareness of kidney disease and relationship to end-stage renal disease and mortality.
|
Am J Med
|
2012
|
2.24
|
|
4
|
Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP).
|
Am J Kidney Dis
|
2010
|
2.18
|
|
5
|
CKD in the United States: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004.
|
Am J Kidney Dis
|
2008
|
1.71
|
|
6
|
Adverse effects of phytoestrogens on reproductive health: a report of three cases.
|
Complement Ther Clin Pract
|
2008
|
1.62
|
|
7
|
The case for low carbohydrate diets in diabetes management.
|
Nutr Metab (Lond)
|
2005
|
1.61
|
|
8
|
Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES).
|
Am J Kidney Dis
|
2009
|
1.52
|
|
9
|
Dietary carbohydrate restriction in type 2 diabetes mellitus and metabolic syndrome: time for a critical appraisal.
|
Nutr Metab (Lond)
|
2008
|
1.44
|
|
10
|
Obstructive sleep apnea and cardiovascular disease: role of the metabolic syndrome and its components.
|
J Clin Sleep Med
|
2008
|
1.38
|
|
11
|
CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004.
|
Am J Kidney Dis
|
2008
|
1.37
|
|
12
|
Abrogation of oxidative stress improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin II overexpression.
|
Am J Physiol Endocrinol Metab
|
2004
|
1.33
|
|
13
|
Association of diabetes and hepatitis C infection: epidemiologic evidence and pathophysiologic insights.
|
Curr Diab Rep
|
2004
|
1.22
|
|
14
|
Hypertension and obesity.
|
Recent Prog Horm Res
|
2004
|
1.20
|
|
15
|
The relationship between hyperinsulinemia, hypertension and progressive renal disease.
|
J Am Soc Nephrol
|
2004
|
1.16
|
|
16
|
Sleep duration and the risk of diabetes mellitus: epidemiologic evidence and pathophysiologic insights.
|
Curr Diab Rep
|
2010
|
1.14
|
|
17
|
Diabetes mellitus in CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition and Examination Survey (NHANES) 1999-2004.
|
Am J Kidney Dis
|
2008
|
1.12
|
|
18
|
Oxidative stress, glucose metabolism, and the prevention of type 2 diabetes: pathophysiological insights.
|
Antioxid Redox Signal
|
2007
|
1.12
|
|
19
|
Heart disease in diabetic patients.
|
Curr Diab Rep
|
2003
|
1.09
|
|
20
|
Diabetes insipidus: diagnosis and treatment of a complex disease.
|
Cleve Clin J Med
|
2006
|
1.08
|
|
21
|
Antiepileptic drugs and bone metabolism.
|
Nutr Metab (Lond)
|
2006
|
1.01
|
|
22
|
Obesity is associated with increased parathyroid hormone levels independent of glomerular filtration rate in chronic kidney disease.
|
Metabolism
|
2009
|
1.00
|
|
23
|
Cardiovascular disease risk reduction with sleep apnea treatment.
|
Expert Rev Cardiovasc Ther
|
2010
|
0.99
|
|
24
|
Cardiometabolic syndrome: pathophysiology and treatment.
|
Curr Hypertens Rep
|
2003
|
0.98
|
|
25
|
Linking sleep duration and obesity among black and white US adults.
|
Clin Pract (Lond)
|
2013
|
0.96
|
|
26
|
Dysglycemia predicts cardiovascular and kidney disease in the Kidney Early Evaluation Program.
|
J Clin Hypertens (Greenwich)
|
2010
|
0.94
|
|
27
|
Obesity, Diabetes, the Cardiorenal Syndrome, and Risk for Cancer.
|
Cardiorenal Med
|
2012
|
0.94
|
|
28
|
Gender disparity in outcomes of care and management for diabetes and the metabolic syndrome.
|
Curr Diab Rep
|
2006
|
0.93
|
|
29
|
Diabetic Cardiovascular Disease Predicts Chronic Kidney Disease Awareness in the Kidney Early Evaluation Program.
|
Cardiorenal Med
|
2011
|
0.93
|
|
30
|
The emerging role of biomarkers in diabetic and hypertensive chronic kidney disease.
|
Curr Diab Rep
|
2010
|
0.93
|
|
31
|
Sleep apnea and diabetes: insights into the emerging epidemic.
|
Curr Diab Rep
|
2011
|
0.92
|
|
32
|
Differential effect of obesity on bone mineral density in White, Hispanic and African American women: a cross sectional study.
|
Nutr Metab (Lond)
|
2005
|
0.92
|
|
33
|
Group visits in the management of diabetes and hypertension: effect on glycemic and blood pressure control.
|
Curr Diab Rep
|
2009
|
0.92
|
|
34
|
Hypertension in pregnancy.
|
Curr Hypertens Rep
|
2005
|
0.92
|
|
35
|
Update on the prevention of type 2 diabetes.
|
Curr Diab Rep
|
2011
|
0.92
|
|
36
|
Diabetes, hypertension, and cardiovascular derangements: pathophysiology and management.
|
Curr Hypertens Rep
|
2004
|
0.90
|
|
37
|
Antihypertensive medications and their effects on lipid metabolism.
|
Curr Diab Rep
|
2008
|
0.88
|
|
38
|
Sudden cardiac death in patients with diabetes.
|
Curr Diab Rep
|
2004
|
0.88
|
|
39
|
The Association between Parathyroid Hormone Levels and the Cardiorenal Metabolic Syndrome in Non-Diabetic Chronic Kidney Disease.
|
Cardiorenal Med
|
2011
|
0.85
|
|
40
|
Heart failure in diabetic patients: utility of beta-blockade.
|
J Card Fail
|
2003
|
0.85
|
|
41
|
Effect of ethnicity on the progression of diabetic kidney disease independent of glycemic control.
|
Am J Nephrol
|
2009
|
0.85
|
|
42
|
New-onset diabetes after hemodialysis initiation: impact on survival.
|
Am J Nephrol
|
2010
|
0.85
|
|
43
|
The association of parathyroid hormone with ESRD and pre-ESRD mortality in the Kidney Early Evaluation Program.
|
J Clin Endocrinol Metab
|
2012
|
0.84
|
|
44
|
Pleiotropic effects of inhibitors of the RAAS in the diabetic population: above and beyond blood pressure lowering.
|
Curr Diab Rep
|
2010
|
0.84
|
|
45
|
Hypertension in patients with Cushing's disease: pathophysiology, diagnosis, and management.
|
Curr Hypertens Rep
|
2005
|
0.83
|
|
46
|
Treatment of hypertension in metabolic syndrome: implications of recent clinical trials.
|
Curr Diab Rep
|
2009
|
0.83
|
|
47
|
Telephone-delivered behavioral intervention among blacks with sleep apnea and metabolic syndrome: study protocol for a randomized controlled trial.
|
Trials
|
2014
|
0.83
|
|
48
|
Review on "Atkins Diabetes Revolution: The Groundbreaking Approach to Preventing and Controlling Type 2 Diabetes" by Mary C. Vernon and Jacqueline A. Eberstein.
|
Nutr Metab (Lond)
|
2004
|
0.82
|
|
49
|
Hypertension in people with diabetes and the metabolic syndrome: pathophysiologic insights and therapeutic update.
|
Curr Diab Rep
|
2007
|
0.82
|
|
50
|
Cardiometabolic syndrome and chronic kidney disease.
|
Curr Diab Rep
|
2006
|
0.81
|
|
51
|
High-dose atorvastatin after stroke or transient ischemic attack: The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators.
|
J Cardiometab Syndr
|
2008
|
0.81
|
|
52
|
Resistant hypertension and sleep apnea: pathophysiologic insights and strategic management.
|
Curr Diab Rep
|
2011
|
0.80
|
|
53
|
Antihypertensive agents, insulin sensitivity, and new-onset diabetes.
|
Curr Diab Rep
|
2007
|
0.79
|
|
54
|
Prevention of type 2 DM: implications for adolescents and young adults.
|
Pediatr Endocrinol Rev
|
2008
|
0.78
|
|
55
|
Cardiovascular risk reduction via increasing HDL cholesterol: the promise of the dal-OUTCOMES Trial.
|
Curr Diab Rep
|
2011
|
0.78
|
|
56
|
High Prevalence of Hypertension and Other Cardiometabolic Risk Factors in US- and Caribbean-Born Blacks with Chest Pain Syndromes.
|
Cardiorenal Med
|
2012
|
0.77
|
|
57
|
Prevention of type 2 diabetes: an update.
|
Curr Diab Rep
|
2007
|
0.77
|
|
58
|
Telmisartan and cardioprotection.
|
Vasc Health Risk Manag
|
2011
|
0.76
|
|
59
|
Narrowed Aortoseptal Angle Is Related to Increased Central Blood Pressure and Aortic Pressure Wave Reflection.
|
Cardiorenal Med
|
2012
|
0.76
|
|
60
|
Uncovering glucose abnormalities in people with hepatitis C infection: should oral glucose tolerance test become a standard of care?
|
Am J Gastroenterol
|
2008
|
0.76
|
|
61
|
Challenges in the diagnosis and management of new-onset diabetes after transplantation.
|
Curr Diab Rep
|
2005
|
0.76
|
|
62
|
Admission hyperglycemia and length of hospital stay in patients with diabetes and heart failure: a prospective cohort study.
|
Congest Heart Fail
|
2008
|
0.76
|
|
63
|
Statins and CVD prevention in the diabetic population: implications of the CARDS trial.
|
Curr Diab Rep
|
2005
|
0.75
|
|
64
|
What are the long-term cardiovascular effects of treatment with rosiglitazone?
|
Curr Diab Rep
|
2008
|
0.75
|
|
65
|
Hypertension management in the high cardiovascular risk population.
|
Int J Hypertens
|
2013
|
0.75
|
|
66
|
ONTARGET: use of ramipril, telmisartan, or both in patients with high cardiovascular risks.
|
Curr Diab Rep
|
2009
|
0.75
|
|
67
|
Hypertension after renal transplant.
|
J Clin Hypertens (Greenwich)
|
2007
|
0.75
|
|
68
|
Calcium channel blockers reduce risk of stroke in people with hypertension. Commentary.
|
Evid Based Cardiovasc Med
|
2005
|
0.75
|
|
69
|
Gender disparities in the control of cardiovascular risk factors in people with diabetes.
|
J Clin Hypertens (Greenwich)
|
2005
|
0.75
|
|
70
|
Hepatitis C and the risk of cardiovascular disease: an evolving epidemic?
|
Expert Rev Cardiovasc Ther
|
2006
|
0.75
|
|
71
|
The Diabetes Prevention Program.
|
Curr Diab Rep
|
2003
|
0.75
|
|
72
|
The DREAM trial and the prospect of diabetes prevention.
|
Curr Diab Rep
|
2006
|
0.75
|
|
73
|
Cardiovascular disease in diabetes and the cardiometabolic syndrome: focus on minority women.
|
Curr Diab Rep
|
2005
|
0.75
|
|
74
|
Mitigating the cardiovascular risk of anemia in patients with type 2 diabetes and CKD: Does darbepoetin help? The TREAT Trial.
|
Curr Diab Rep
|
2010
|
0.75
|
|
75
|
Posttransplant diabetes and hypertension: pathophysiologic insights and therapeutic rationale.
|
Curr Diab Rep
|
2008
|
0.75
|
|
76
|
Clinical trials report. Hypertensive diabetic patients: INVESTing in the prevention of cardiovascular disease.
|
Curr Hypertens Rep
|
2005
|
0.75
|
|
77
|
Heart failure: metabolic derangements and therapeutic rationale.
|
Expert Rev Cardiovasc Ther
|
2007
|
0.75
|
|
78
|
Stroke prevention in diabetic and other high cardiovascular risk patients.
|
Curr Diab Rep
|
2005
|
0.75
|
|
79
|
When the heart and the mind collide: cardiovascular risk factors and antipsychotic use in the schizophrenic population.
|
J Cardiometab Syndr
|
2009
|
0.75
|
|
80
|
Bone mineral density in African–American women with symptomatic uterine leiomyoma.
|
Womens Health (Lond Engl)
|
2010
|
0.75
|
|
81
|
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack (ALLHAT) Trial: focus on the diabetic patient.
|
Curr Hypertens Rep
|
2004
|
0.75
|
|
82
|
Therapeutic interventions for hypertension in metabolic syndrome: a comprehensive approach.
|
Expert Rev Cardiovasc Ther
|
2007
|
0.75
|
|
83
|
Challenges in the diagnosis and management of renal artery stenosis.
|
Curr Hypertens Rep
|
2005
|
0.75
|